Giant Biogene Holding Co Ltd

Net income margin, %

40.7

1.4

EBITDA margin, %

49.8

7.8

Debt to Equity, %

0

17.7

Intangible assets and goodwill, %

0.1

2.4

Revenue CAGR 3Y, %

43.5

6.9

Revenue Y, % chg

41.6

0

P/E

27.3

25

P/BV

9.2

1.3

P/S

11.4

1.6

EV/S

10.3

1.6

EV/EBITDA

21.1

6.9

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

20.9

27.4

Forward P/E

20.7

17

Dividend Yield, %

1

1.9

Forward Dividend Yield, %

0.1

0.1

Expected dividend per share

0

0.1

Payout Ratio, %

0

25.9

Dividend Ex Date

2024-06-17